A phase III trial evaluated intermediate-dose cytarabine plus granulocyte-colony stimulating factor (G-CSF) vs G-CSF alone prior to autoSCT in multiple myeloma.
Lauren M. Dembeck
Advertisement
Articles by Lauren M. Dembeck
Advertisement
Latest Updated Articles
Advertisement
Advertisement